T-DM1: New "smart" drug for breast cancer extends women"s live by almost six months

New 'smart' drug for breast cancer extends women's lives by almost six months Novel treatment also reduces toxic side effects including hair lossDrug combines Herceptin and a chemotherapy agent Campaigners say it offers 'precious lifeline' for those with most aggressive cancer | UPDATED: 16:20 GMT, 1 October 2012 A new ‘smart’ drug for breast cancer extends women’s lives by almost six months while reducing toxic side effects – including hair loss.

Controversial Down"s syndrome testing gets go-ahead in Switzerland

Controversial pre-natal Down's syndrome testing gets go-ahead in Switzerland raising fears of a spike in abortions The test involves screening blood samples from the pregnant woman for the presence of foetal Down's syndrome | UPDATED: 14:25 GMT, 30 July 2012 A new prenatal test for Down's syndrome has been given the green light in Switzerland amid controversy over whether this will lead to more abortions.